"The times they are a-changin'." In reply to El-Zaidy et al.: AVXS-101 (Onasemnogene Abeparvovec) for SMA1: comparative study with a prospective natural history cohort (Journal of Neuromuscular Diseases, 2019)

(untitled) - Servais, L